SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63361 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63299Maybe: In its Q3 2025 report, Monte Rosa announced a major new collaboration witsysiphus211/24/2025
63298Guess that got something "unstuck" :)Davidoff111/24/2025
63297GLUE: My poetry contribution for today: Anyone got a clue What is up with GLUEerickerickson-11/24/2025
63296IBRX NewsNation is airing an hour-long spplhky3465-11/24/2025
63295Yeah, saw that. Seems like we've been here before with some other company...erickerickson111/18/2025
63294Erick, fwiw ORGN is seeking approval of a floorless convertible. The $.62 converghettogoulash111/17/2025
63293My friends at Wells Fargo were bigger supporters. it's cost me But they fouEMU2-11/12/2025
63292Anavex (AVXL) had a preauthorization oral explanation meeting with the FDA yesteOlecranon111/12/2025
63291re: GLUE up 14% after a poster presentation? Poster presentation Saturday All erickerickson111/10/2025
63290Finally out of Auph with a nice profit. Had to average down a number of times bgalt-11/9/2025
63289AUPH is gaining on SRPT, who would have thought.idahoranch1211/7/2025
63288Gilead fails late-stage trial for Trodelvy in first-line breast cancerDavidoff-11/7/2025
63287Expert witness hahaha. These Federal F*cks just copy and pasted everything Heilbghettogoulash111/6/2025
63286Just saw this. The U.S. Department of Justice dismissed with prejudice all chargghettogoulash211/6/2025
63285I continue to be impressed by the number of ways there are to lose holding a bioallatwwk611/5/2025
63284Two things I don't like about Sarepta's spin on trial data: (1) The Statghettogoulash111/5/2025
63283Indeed, this will be a tough sell to Prasad & Co. Then again, it's gonnaghettogoulash211/5/2025
63282Olecranon, I share your general concern about Sarepta. I think for EXONDYS 51 ibodish311/4/2025
63281I’ve been maybe Sarepta’s biggest permabull. This really puts a hitch in my giddOlecranon111/4/2025
63280> which could impact the transition from accelerated to traditional approval li3511311/4/2025
63279> How can a public figure make such statements that they know will move the mli3511111/4/2025
63278Srpt. The ESSENCE trial did not reach statistical significance on its primary enerippetoe111/4/2025
63277Case 1:25-cv-03593 Document 1 Filed 11/02/25 Page 1 of 32 IN THE UNITED STATES dorightbythem211/3/2025
63276Me too, just find it interestingerippetoe-10/28/2025
63275I will be avoiding this.Olecranon-10/28/2025
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News